Stimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review

Acute ischemic stroke (AIS) is a common devastating disease that has increased yearly in absolute number of cases since 1990. While mechanical thrombectomy and tissue plasminogen activator (tPA) have proven to be effective treatments, their window-of-efficacy time is very short, leaving many patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Turner S. Baker, Justin Robeny, Danna Cruz, Alexis Bruhat, Alfred-Marc Iloreta, Anthony Costa, Thomas James Oxley
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/9740328999914ddab60ac8700f328355
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9740328999914ddab60ac8700f328355
record_format dspace
spelling oai:doaj.org-article:9740328999914ddab60ac8700f3283552021-11-18T06:05:10ZStimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review1664-229510.3389/fneur.2021.753182https://doaj.org/article/9740328999914ddab60ac8700f3283552021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fneur.2021.753182/fullhttps://doaj.org/toc/1664-2295Acute ischemic stroke (AIS) is a common devastating disease that has increased yearly in absolute number of cases since 1990. While mechanical thrombectomy and tissue plasminogen activator (tPA) have proven to be effective treatments, their window-of-efficacy time is very short, leaving many patients with no viable treatment option. Over recent years there has been a growing interest in stimulating the facial nerves or ganglions to treat AIS. Pre-clinical studies have consistently demonstrated an increase in collateral blood flow (CBF) following ganglion stimulation, with positive indications in infarct size and neurological scores. Extensive human trials have focused on trans-oral electrical stimulation of the sphenopalatine ganglion, but have suffered from operational limitations and non-significant clinical findings. Regardless, the potential of ganglion stimulation to treat AIS or elongate the window-of-efficacy for current stroke treatments remains extremely promising. This review aims to summarize results from recent trial publications, highlight current innovations, and discuss future directions for the field. Importantly, this review comes after the release of four important clinical trials that were published in mid 2019.Turner S. BakerTurner S. BakerJustin RobenyJustin RobenyDanna CruzDanna CruzAlexis BruhatAlexis BruhatAlfred-Marc IloretaAnthony CostaAnthony CostaThomas James OxleyThomas James OxleyFrontiers Media S.A.articleanimal studiescerebral blood flowcerebrovascular diseasevascular surgerystrokeNeurology. Diseases of the nervous systemRC346-429ENFrontiers in Neurology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic animal studies
cerebral blood flow
cerebrovascular disease
vascular surgery
stroke
Neurology. Diseases of the nervous system
RC346-429
spellingShingle animal studies
cerebral blood flow
cerebrovascular disease
vascular surgery
stroke
Neurology. Diseases of the nervous system
RC346-429
Turner S. Baker
Turner S. Baker
Justin Robeny
Justin Robeny
Danna Cruz
Danna Cruz
Alexis Bruhat
Alexis Bruhat
Alfred-Marc Iloreta
Anthony Costa
Anthony Costa
Thomas James Oxley
Thomas James Oxley
Stimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review
description Acute ischemic stroke (AIS) is a common devastating disease that has increased yearly in absolute number of cases since 1990. While mechanical thrombectomy and tissue plasminogen activator (tPA) have proven to be effective treatments, their window-of-efficacy time is very short, leaving many patients with no viable treatment option. Over recent years there has been a growing interest in stimulating the facial nerves or ganglions to treat AIS. Pre-clinical studies have consistently demonstrated an increase in collateral blood flow (CBF) following ganglion stimulation, with positive indications in infarct size and neurological scores. Extensive human trials have focused on trans-oral electrical stimulation of the sphenopalatine ganglion, but have suffered from operational limitations and non-significant clinical findings. Regardless, the potential of ganglion stimulation to treat AIS or elongate the window-of-efficacy for current stroke treatments remains extremely promising. This review aims to summarize results from recent trial publications, highlight current innovations, and discuss future directions for the field. Importantly, this review comes after the release of four important clinical trials that were published in mid 2019.
format article
author Turner S. Baker
Turner S. Baker
Justin Robeny
Justin Robeny
Danna Cruz
Danna Cruz
Alexis Bruhat
Alexis Bruhat
Alfred-Marc Iloreta
Anthony Costa
Anthony Costa
Thomas James Oxley
Thomas James Oxley
author_facet Turner S. Baker
Turner S. Baker
Justin Robeny
Justin Robeny
Danna Cruz
Danna Cruz
Alexis Bruhat
Alexis Bruhat
Alfred-Marc Iloreta
Anthony Costa
Anthony Costa
Thomas James Oxley
Thomas James Oxley
author_sort Turner S. Baker
title Stimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review
title_short Stimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review
title_full Stimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review
title_fullStr Stimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review
title_full_unstemmed Stimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review
title_sort stimulating the facial nerve to treat ischemic stroke: a systematic review
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/9740328999914ddab60ac8700f328355
work_keys_str_mv AT turnersbaker stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT turnersbaker stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT justinrobeny stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT justinrobeny stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT dannacruz stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT dannacruz stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT alexisbruhat stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT alexisbruhat stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT alfredmarciloreta stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT anthonycosta stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT anthonycosta stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT thomasjamesoxley stimulatingthefacialnervetotreatischemicstrokeasystematicreview
AT thomasjamesoxley stimulatingthefacialnervetotreatischemicstrokeasystematicreview
_version_ 1718424619523768320